BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36715363)

  • 1. Prediagnostic serum glyceraldehyde-derived advanced glycation end products and mortality among colorectal cancer patients.
    Mao Z; Baker JR; Takeuchi M; Hyogo H; Tjønneland A; Eriksen AK; Severi G; Rothwell J; Laouali N; Katzke V; Kaaks R; Schulze MB; Palli D; Sieri S; de Magistris MS; Tumino R; Sacerdote C; Derksen JWG; Gram IT; Skeie G; Sandanger TM; Quirós JR; Crous-Bou M; Sánchez MJ; Amiano P; Colorado-Yohar SM; Guevara M; Harlid S; Johansson I; Perez-Cornago A; Freisling H; Gunter M; Weiderpass E; Heath AK; Aglago E; Jenab M; Fedirko V
    Int J Cancer; 2023 Jun; 152(11):2257-2268. PubMed ID: 36715363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association between Glyceraldehyde-Derived Advanced Glycation End-Products and Colorectal Cancer Risk.
    Kong SY; Takeuchi M; Hyogo H; McKeown-Eyssen G; Yamagishi S; Chayama K; O'Brien PJ; Ferrari P; Overvad K; Olsen A; Tjønneland A; Boutron-Ruault MC; Bastide N; Carbonnel F; Kühn T; Kaaks R; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Vasilopoulou E; Masala G; Pala V; Santucci De Magistris M; Tumino R; Naccarati A; Bueno-de-Mesquita HB; Peeters PH; Weiderpass E; Quirós JR; Jakszyn P; Sánchez MJ; Dorronsoro M; Gavrila D; Ardanaz E; Rutegård M; Nyström H; Wareham NJ; Khaw KT; Bradbury KE; Romieu I; Freisling H; Stavropoulou F; Gunter MJ; Cross AJ; Riboli E; Jenab M; Bruce WR
    Cancer Epidemiol Biomarkers Prev; 2015 Dec; 24(12):1855-63. PubMed ID: 26404963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary Intake of Advanced Glycation End Products (AGEs) and Mortality among Individuals with Colorectal Cancer.
    Mao Z; Aglago EK; Zhao Z; Schalkwijk C; Jiao L; Freisling H; Weiderpass E; Hughes DJ; Eriksen AK; Tjønneland A; Severi G; Rothwell J; Boutron-Ruault MC; Katzke V; Kaaks R; Schulze MB; Birukov A; Krogh V; Panico S; Tumino R; Ricceri F; Bueno-de-Mesquita HB; Vermeulen RCH; Gram IT; Skeie G; Sandanger TM; Quirós JR; Crous-Bou M; Sánchez MJ; Amiano P; Chirlaque MD; Barricarte Gurrea A; Manjer J; Johansson I; Perez-Cornago A; Jenab M; Fedirko V
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary Advanced Glycation End-Products and Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study.
    Aglago EK; Mayén AL; Knaze V; Freisling H; Fedirko V; Hughes DJ; Jiao L; Eriksen AK; Tjønneland A; Boutron-Ruault MC; Rothwell JA; Severi G; Kaaks R; Katzke V; Schulze MB; Birukov A; Palli D; Sieri S; Santucci de Magistris M; Tumino R; Ricceri F; Bueno-de-Mesquita B; Derksen JWG; Skeie G; Gram IT; Sandanger T; Quirós JR; Luján-Barroso L; Sánchez MJ; Amiano P; Chirlaque MD; Gurrea AB; Johansson I; Manjer J; Perez-Cornago A; Weiderpass E; Gunter MJ; Heath AK; Schalkwijk CG; Jenab M
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a monoclonal antibody-based ELISA system for glyceraldehyde-derived advanced glycation end products.
    Matsui T; Joo HD; Lee JM; Ju SM; Tao WH; Higashimoto Y; Fukami K; Yamagishi S
    Immunol Lett; 2015 Oct; 167(2):141-6. PubMed ID: 26304702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The formation of intracellular glyceraldehyde-derived advanced glycation end-products and cytotoxicity.
    Takino J; Kobayashi Y; Takeuchi M
    J Gastroenterol; 2010 Jun; 45(6):646-55. PubMed ID: 20084527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycer-AGEs-RAGE signaling enhances the angiogenic potential of hepatocellular carcinoma by upregulating VEGF expression.
    Takino J; Yamagishi S; Takeuchi M
    World J Gastroenterol; 2012 Apr; 18(15):1781-8. PubMed ID: 22553402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered serum glyceraldehyde-derived advanced glycation end product (AGE) and soluble AGE receptor levels indicate carbonyl stress in patients with schizophrenia.
    Takeda M; Ohnuma T; Takeuchi M; Katsuta N; Maeshima H; Takebayashi Y; Higa M; Nakamura T; Nishimon S; Sannohe T; Hotta Y; Hanzawa R; Higashiyama R; Shibata N; Gohda T; Suzuki Y; Yamagishi S; Tomino Y; Arai H
    Neurosci Lett; 2015 Apr; 593():51-5. PubMed ID: 25766756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glyceraldehyde-derived advanced glycation end-products are associated with left ventricular ejection fraction and brain natriuretic peptide in patients with diabetic adverse cardiac remodeling.
    Yasuda Y; Aoki H; Fujita W; Fujibayashi K; Wakasa M; Kawai Y; Nakanishi H; Saito K; Takeuchi M; Kajinami K
    Scand Cardiovasc J; 2022 Dec; 56(1):208-216. PubMed ID: 35792728
    [No Abstract]   [Full Text] [Related]  

  • 10. Glyceraldehyde-Derived Pyridinium Evokes Renal Tubular Cell Damage via RAGE Interaction.
    Sotokawauchi A; Nakamura N; Matsui T; Higashimoto Y; Yamagishi SI
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation end products impair glucose-induced insulin secretion from rat pancreatic β-cells.
    Hachiya H; Miura Y; Inoue K; Park KH; Takeuchi M; Kubota K
    J Hepatobiliary Pancreat Sci; 2014 Feb; 21(2):134-41. PubMed ID: 23798335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer malignancy is enhanced by glyceraldehyde-derived advanced glycation end-products.
    Takino J; Yamagishi S; Takeuchi M
    J Oncol; 2010; 2010():739852. PubMed ID: 20631911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of glyceraldehyde-derived advanced glycation end-products in the liver of insulin-resistant mice.
    Ebata Y; Takino J; Tsuchiya H; Sakabe T; Ikeda Y; Hama S; Kogure K; Takeuchi M; Shiota G
    Int J Vitam Nutr Res; 2013; 83(2):137-41. PubMed ID: 24491887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to the Paleolithic diet and Paleolithic-like lifestyle reduce the risk of colorectal cancer in the United States: a prospective cohort study.
    Xiao Y; Wang Y; Gu H; Xu Z; Tang Y; He H; Peng L; Xiang L
    J Transl Med; 2023 Jul; 21(1):482. PubMed ID: 37468920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced glycation end products, soluble receptor for advanced glycation end products, and risk of colorectal cancer.
    Jiao L; Taylor PR; Weinstein SJ; Graubard BI; Virtamo J; Albanes D; Stolzenberg-Solomon RZ
    Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1430-8. PubMed ID: 21527578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-diagnostic circulating resistin concentrations and mortality among individuals with colorectal cancer: Results from the European Prospective Investigation into Cancer and Nutrition study.
    Pham TT; Nimptsch K; Aleksandrova K; Jenab M; Fedirko V; Wu K; Eriksen AK; Tjønneland A; Severi G; Rothwell J; Kaaks R; Katzke V; Catalano A; Agnoli C; Masala G; De Magistris MS; Tumino R; Vermeulen R; Aizpurua A; Trobajo-Sanmartín C; Chirlaque MD; Sánchez MJ; Lu SSM; Cross AJ; Christakoudi S; Weiderpass E; Pischon T
    Int J Cancer; 2024 May; 154(9):1596-1606. PubMed ID: 38200695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease.
    Takeuchi M; Yamagishi S
    Curr Pharm Des; 2008; 14(10):973-8. PubMed ID: 18473848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediagnostic Blood Selenium Status and Mortality among Patients with Colorectal Cancer in Western European Populations.
    Baker JR; Umesh S; Jenab M; Schomburg L; Tjønneland A; Olsen A; Boutron-Ruault MC; Rothwell JA; Severi G; Katzke V; Johnson T; Schulze MB; Masala G; Agnoli C; Simeon V; Tumino R; Bueno-de-Mesquita HB; Gram IT; Skeie G; Bonet C; Rodriguez-Barranco M; Houerta JM; Gylling B; Van Guelpen B; Perez-Cornago A; Aglago E; Freisling H; Weiderpass E; Cross AJ; Heath AK; Hughes DJ; Fedirko V
    Biomedicines; 2021 Oct; 9(11):. PubMed ID: 34829750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentrations of advanced glycation end-products and colorectal cancer risk in the EPIC study.
    Aglago EK; Schalkwijk CG; Freisling H; Fedirko V; Hughes DJ; Jiao L; Dahm CC; Olsen A; Tjønneland A; Katzke V; Johnson T; Schulze MB; Aleksandrova K; Masala G; Sieri S; Simeon V; Tumino R; Macciotta A; Bueno-de-Mesquita B; Skeie G; Gram IT; Sandanger T; Jakszyn P; Sánchez MJ; Amiano P; Colorado-Yohar SM; Gurrea AB; Perez-Cornago A; Mayén AL; Weiderpass E; Gunter MJ; Heath AK; Jenab M
    Carcinogenesis; 2021 May; 42(5):705-713. PubMed ID: 33780524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro identification of nonalcoholic fatty liver disease-related protein hnRNPM.
    Takino J; Nagamine K; Takeuchi M; Hori T
    World J Gastroenterol; 2015 Feb; 21(6):1784-93. PubMed ID: 25684943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.